Question explored with the scientific record
Conversation so far
- 1 Vitamins might be needed for a 6th month pregnant woman who eats a lot of processed food
- 2 Folic acid or folate. Which is better.
Answered on this page ↓
Folic acid or folate. Which is better.
Folic acid has the hard outcomes. Methylfolate has cleaner bloodwork. For preventing birth defects, that gap matters.
For the outcome that counts, neural tube defects, folic acid is the proven form. Randomized trials show periconceptional folic acid prevents up to two-thirds of them [2], and the MRC trial cut recurrence from about 3.5% to 1% [1]. The Hungarian trial found no defects in the vitamin arm versus six in the trace-element arm [1]. No trial in this evidence shows methylfolate prevents a single birth defect. That is the whole ballgame for pregnancy.
Methylfolate (5-MTHF) wins on a surrogate: a 2026 trial of 62 women found it kept folate levels equal while cutting unmetabolized folic acid, the unprocessed leftover, in maternal blood and placenta [3]. That leftover is a lab marker, not a disease. Whether it harms anyone is unproven.
| Form | Proven benefit | Proven harm |
|---|---|---|
| Folic acid | Cuts NTDs up to two-thirds [2] | Leaves unmetabolized folic acid in blood [3] |
| 5-MTHF | Matches folate levels [3] | No NTD outcome data |
One honest worry: a meta-analysis of 10 trials found a borderline rise in overall cancer with folic acid, though doses ran from 800 mcg to 40 mg and often included B12 [2]. A U-shaped risk curve has been proposed, lowest around 300-400 mcg daily [2]. That argues for standard doses, not megadoses.
My call: for preventing birth defects, folic acid at standard prenatal dose is the better-evidenced choice; methylfolate is a reasonable substitute only if she carries an MTHFR variant or reacts badly to folic acid, and that is a guess, not a proven advantage. Confidence: moderate.
Sources used 3
-
Periconceptional folic acid and the prevention of neural tube defects: Some food for thought for Canadian paediatricians
Randomized trials show periconceptional folic acid prevents recurrence and first occurrence of neural tube defects, but a Canadian survey found few women took periconceptional supplements and local spina bifida referrals did not decline, supporting fortification and education.
DOI: 10.1093/pch/2.2.114 -
Folic acid fortification prevents neural tube defects and may also reduce cancer risks
This review argues that mandatory folic acid fortification effectively prevents neural tube defects and that cancer-risk concerns are not supported at physiological intake levels, recommending EU implementation soon.
DOI: 10.1111/j.1651-2227.2012.02781.x -
Using 6S-5-methyltetrahydrofolate instead of folic acid in prenatal multivitamin reduces unmetabolized folic acid concentrations in the mother-fetus dyad: a 24-week randomized controlled trial
A 24-week randomized trial in 62 pregnant women found 6S-5-methyltetrahydrofolate maintained maternal and fetal total folate while lowering unmetabolized folic acid in blood and placenta compared to folic acid.
DOI: 10.3389/fnut.2026.1679067